1. Characterisation and differential diagnosis of neurological complications in adults with phenylketonuria: literature review and expert opinion

   • Martin Merkel
   • Daniela Berg
   • Ania C. Muntau

   Review Open access 20 April 2023 Pages: 3675 - 3687

   

2. Neuropathology of New-Onset Refractory Status Epilepticus (NORSE)

   • Aurélie Hanin
   • Jorge Cespedes
   • Eleonora Aronica

   Review 20 April 2023 Pages: 3688 - 3702

   

3. Autonomic nervous system disorders in multiple sclerosis

   • Effrosyni Koutsouraki
   • Koukoulidis Theodoros
   • Michmizos Dimitrios

   Review 21 April 2023 Pages: 3703 - 3713

4. Ordering genetic testing by neurologists: points to consider

   • Avi Fellner
   • Yael Goldberg
   • Lina Basel-Salmon

   Review 08 May 2023 Pages: 3714 - 3722

   

5. Recent advances in novel mutation genes of Parkinson's disease

   • Jie Yang
   • Xinyu Wu
   • Yuning Song

   Review 24 May 2023 Pages: 3723 - 3732

   

6. Duchenne muscular dystrophy: pathogenesis and promising therapies

   • Mengyuan Chang
   • Yong Cai
   • Hualin Sun

   Review 01 June 2023 Pages: 3733 - 3749

   

7. Changes in motor activity level in individuals with frontotemporal dementia

   • C. R. A. Silveira
   • E. Mitchell
   • E. Finger

   Original Communication 16 April 2023 Pages: 3750 - 3757

   

8. Multiple sclerosis optic neuritis and trans-synaptic pathology on cortical thinning in people with multiple sclerosis

   • Ranjani Ganapathy Subramanian
   • Robert Zivadinov
   • Dejan Jakimovski

   Original Communication 17 April 2023 Pages: 3758 - 3769

   

9. Progressive supranuclear palsy’s economical burden: the use and costs of healthcare resources in a large health provider in Israel

   • Yael Barer
   • Raanan Cohen
   • Gabriel Chodick

   Original Communication Open access 17 April 2023 Pages: 3770 - 3778

   

10. Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

    • Tobias Monschein
    • Sarinah Dekany
    • the Austrian MS Treatment Registry (AMSTR)

    Original Communication Open access 19 April 2023 Pages: 3779 - 3786

    

11. Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

    • Tobias Monschein
    • Sarinah Dekany
    • the Austrian MS Treatment Registry (AMSTR)

    Correction Open access 05 June 2023 Pages: 3787 - 3787

12. The potential value of disease-modifying therapy in patients with spinocerebellar ataxia type 1: an early health economic modeling study

    • Teije van Prooije
    • Sanne Ruigrok
    • Janneke P. C. Grutters

    Original Communication Open access 19 April 2023 Pages: 3788 - 3798

    

13. Correction to: The potential value of disease-modifying therapy in patients with spinocerebellar ataxia type 1: an early health economic modeling study

    • Teije van Prooije
    • Sanne Ruigrok
    • Janneke P. C. Grutters

    Correction Open access 08 May 2023 Pages: 3799 - 3799

14. Diagnosing the benign paroxysmal positional vertigo via 1D and deep-learning composite model

    • Peixia Wu
    • Xuebing Liu
    • Wenyan Li

    Original Communication 20 April 2023 Pages: 3800 - 3809

    

15. Data lake-driven analytics identify nocturnal non-dipping of heart rate as predictor of unfavorable stroke outcome at discharge

    • Alexander Nelde
    • Markus G. Klammer
    • Christian Meisel

    Original Communication Open access 20 April 2023 Pages: 3810 - 3820

    

16. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease

    • Ane Murueta-Goyena
    • Rocío Del Pino
    • Juan Carlos Gómez Esteban

    Original Communication Open access 20 April 2023 Pages: 3821 - 3829

    

17. Serum neurofilament light chain levels are associated with all-cause mortality in the general US population

    • Stefano Ciardullo
    • Emanuele Muraca
    • Gianluca Perseghin

    Original Communication Open access 21 April 2023 Pages: 3830 - 3838

    

18. Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study

    • Monica Margoni
    • Elisabetta Pagani
    • Massimo Filippi

    Original Communication 24 April 2023 Pages: 3839 - 3850

    

19. A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort

    • Maureen van Dam
    • Brigit A. de Jong
    • Hanneke E. Hulst

    Original Communication Open access 27 April 2023 Pages: 3851 - 3861

    

20. Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension

    • Andreas Meisel
    • Djillali Annane
    • the CHAMPION MG Study Group

    Original Communication Open access 27 April 2023 Pages: 3862 - 3875

    

21. Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study

    • Yuting Luo
    • Zhixin Cao
    • Xunsha Sun

    Original Communication 27 April 2023 Pages: 3876 - 3884

    

22. Comparison of spinal magnetic resonance imaging and classical clinical factors in predicting motor capacity in amyotrophic lateral sclerosis

    • M. Khamaysa
    • M. Lefort
    • the Pulse study group

    Original Communication 27 April 2023 Pages: 3885 - 3895

    

23. Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015–2022): 2022 interim analysis

    • Eugenio Mercuri
    • Andrés Nascimento Osorio
    • the STRIDE and CINRG DNHS investigators

    Original Communication Open access 28 April 2023 Pages: 3896 - 3913

    

24. Encephalitis in HIV-infected adults in the antiretroviral therapy era

    • Melissa Reimer-Mcatee
    • Denisse Ramirez
    • Rodrigo Hasbun

    Original Communication 28 April 2023 Pages: 3914 - 3933

25. The phenotypic spectrum of epilepsy associated with periventricular nodular heterotopia

    • Karina Paliotti
    • Christelle Dassi
    • Kenneth A. Myers

    Original Communication 29 April 2023 Pages: 3934 - 3945

    

26. Muscle MRI patterns for limb girdle muscle dystrophies: systematic review

    • Issa Alawneh
    • Ana Stosic
    • Hernan Gonorazky

    Original Communication 02 May 2023 Pages: 3946 - 3957

    

27. Decreased aperiodic neural activity in Parkinson’s disease and dementia with Lewy bodies

    • Yevgenia Rosenblum
    • Tamara Shiner
    • Anat Mirelman

    Original Communication 03 May 2023 Pages: 3958 - 3969

    

28. Genetic characterization of primary lateral sclerosis

    • Eva M. J. de Boer
    • Balint S. de Vries
    • Michael A. van Es

    Original Communication Open access 03 May 2023 Pages: 3970 - 3980

    

29. Gadolinium contrast agents: dermal deposits and potential effects on epidermal small nerve fibers

    • Heidrun H. Krämer
    • Patrick Bücker
    • Christoph van Thriel

    Original Communication Open access 04 May 2023 Pages: 3981 - 3991

    

30. Self-reported life-space mobility in the first year after ischemic stroke: longitudinal findings from the MOBITEC-Stroke project

    • Timo Hinrichs
    • Roland Rössler
    • Nils Peters

    Original Communication Open access 04 May 2023 Pages: 3992 - 4003

    

31. Cortical involvement in essential tremor with and without rest tremor: a machine learning study

    • Maria Giovanna Bianco
    • Andrea Quattrone
    • Aldo Quattrone

    Original Communication Open access 05 May 2023 Pages: 4004 - 4012

    

32. Identifying novel genes for amyotrophic lateral sclerosis by integrating human brain proteomes with genome-wide association data

    • Xiao-Jing Gu
    • Wei-Ming Su
    • Yong-Ping Chen

    Original Communication 06 May 2023 Pages: 4013 - 4023

    

33. Microvascular involvement in migraine: an optical coherence tomography angiography study

    • Marina Romozzi
    • Giovanni Cuffaro
    • Catello Vollono

    Original Communication 08 May 2023 Pages: 4024 - 4030

    

34. Memory-guided navigation in amyotrophic lateral sclerosis

    • Patrizia M. Maier
    • Deetje Iggena
    • Christoph J. Ploner

    Original Communication Open access 08 May 2023 Pages: 4031 - 4040

    

35. Dynamic changes of the direction and angle of radiographic ocular lateral deviation in patients with lateropulsion after stroke onset

    • Masatoshi Kamada
    • Chiaki Yokota
    • Hiroaki Nishizono

    Original Communication 09 May 2023 Pages: 4041 - 4048

    

36. Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study

    • B. Ratajczak-Tretel
    • A. Tancin Lambert
    • NOR-FIB study group

    Original Communication Open access 10 May 2023 Pages: 4049 - 4059

    

37. Neurological and imaging phenotypes of adults with untreated phenylketonuria: new cases and literature review

    • Meng-Wen Wang
    • Chu-Jun Wu
    • Zai-Qiang Zhang

    Original Communication 10 May 2023 Pages: 4060 - 4079

    

38. Large diameter hemicraniectomy does not improve long-term outcome in malignant infarction

    • Dominik Lehrieder
    • Hans-Peter Müller
    • on behalf of the DESTINY-R (DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY - Registry) Study Group and IGNITE (Initiative of German NeuroIntensive Trial Engagement) Study Group

    Original Communication Open access 10 May 2023 Pages: 4080 - 4089

    

39. Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patients

    • Edoardo Nicolò Aiello
    • Federica Solca
    • Barbara Poletti

    Short Commentary 05 May 2023 Pages: 4090 - 4095

    

40. Understanding social media: how its popularity could be used to advance medical education in stroke care?

    • Gustavo Saposnik

    Short Commentary 18 May 2023 Pages: 4096 - 4102

    

41. Sequential and combined central retinal artery occlusion and anterior ischemic optic neuropathy in Fabry’s disease

    • André Sobral-Pinho
    • André Jorge
    • João Lemos

    Letter to the Editors 25 April 2023 Pages: 4103 - 4106

    

42. Acetyl-DL-leucine in combination with memantine improves acquired pendular nystagmus caused by multiple sclerosis: a case report

    • O. Kremmyda
    • K. Feil
    • M. Strupp

    Letter to the Editors Open access 27 April 2023 Pages: 4107 - 4109

    

43. Vestibular schwannoma presenting with Valsalva maneuver-induced nystagmus

    • Ana Abičić
    • Ivan Adamec
    • Mario Habek

    Letter to the Editors 28 April 2023 Pages: 4110 - 4111

    

44. Short-read genome sequencing allows ‘en route’ diagnosis of patients with atypical Friedreich ataxia

    • Zofia Fleszar
    • Claudia Dufke
    • Matthis Synofzik

    Letter to the Editors Open access 29 April 2023 Pages: 4112 - 4117

    

45. Autoimmune encephalitis: recent clinical and biological advances

    • James A. Varley
    • Christine Strippel
    • Sarosh R. Irani

    Neurological Update Open access 28 April 2023 Pages: 4118 - 4131

    

46. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges

    • Abdullah Al-Ani
    • John J. Chen
    • Fiona Costello

    Neurological Update 08 May 2023 Pages: 4132 - 4150

    

47. Path from discovery to recovery: therapeutic and diagnostic advances in Alzheimer's dementia

    • Aung M. Saw
    • James Hrastelj
    • Neil P. Robertson

    Journal club Open access 03 July 2023 Pages: 4151 - 4153

48. John Charles Bucknill (1817–1897)

    • Andrew J. Larner
    • Christopher Gardner-Thorpe

    Pioneers in Neurology 05 July 2023 Pages: 4154 - 4155

    

49. Correction to: Development of a diagnostic framework for vestibular causes of dizziness and unsteadiness in patients with multisensory neurological disease: a Delphi consensus

    • Amanda J. Male
    • Sarah L. Holmes
    • Diego Kaski

    Correction 06 April 2023 Pages: 4156 - 4156